With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.57196-62-0,6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride,as a common compound, the synthetic route is as follows.,57196-62-0
6-Methoxy-1,2,4,4-tetrahydroisoquinoline hydrochloride (2.0 g, 10 mmol) and triethylamine (3.03 g, 30 mmol) were dissolved in dichloromethane (100 mL) Di-tert-butyl dicarbonate (2.62 g, 12 mmol) was added and reacted at room temperature for 2 hours. (50 mL), the organic phase was combined, washed with saturated brine, dried over anhydrous sodium sulfate and concentrated in vacuo to give the crude product (3.0 g).
As the paragraph descriping shows that 57196-62-0 is playing an increasingly important role.
Reference£º
Patent; Shandong Xuanzhu Pharmaceutical Technology Co., Ltd.; Wu Yongqian; (29 pag.)CN104876914; (2017); B;,
Tetrahydroisoquinoline – Wikipedia
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem